Pharma Supply Shift Amid US Tariff Risks
Professor Amrahi Buang, President, Malaysia Pharmacists Society
16-Apr-25 07:45

Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
As the U.S. considers new tariffs on imported pharmaceuticals, Malaysia is preparing for potential supply disruptions. In response, the government is exploring alternative sources from China and India to lessen reliance on U.S. imports. We discuss the implications and next steps with Prof. Amrahi Buang of the Malaysia Pharmacists Society.
Image Credit: Shutterstock.com
Produced by: Tun Hizami Hashim
Presented by: Aisalli Ayub, Keith Kam, Shazana Mokhtar
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: controversies, international, economy
Tags: trump, pharmaceuticals, import tariffs, china, india,